NuvOx Pharma is a biotechnology company specializing in oxygen therapeutics. Its formulations are based on dodecafluoropentane emulsion (DDFPe). The company aims to provide treatments for stroke, hypoxic solid tumors, sickle cell crisis, hemorrhagic shock, traumatic brain injury, and myocardial infarction.